Quarterly report pursuant to Section 13 or 15(d)

Nature of Business and Liquidity (Details)

v3.24.1.1.u2
Nature of Business and Liquidity (Details)
$ in Thousands
3 Months Ended
Aug. 15, 2023
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Line of Credit Facility [Line Items]        
Reverse stock split conversion ratio 0.01667      
Accumulated deficit   $ 121,607   $ 116,995
Cash   290   $ 1,059
Net loss   4,612 $ 2,300  
Net cash used in operating activities   2,677 $ 4,728  
Equity letter of credit        
Line of Credit Facility [Line Items]        
Equity line of credit   $ 50,000